Postpartum depression (PPD) represent around 15% of birth in developed countries. The context of the COVID-19 epidemy represents a possible source of additional emotional distress. The objective of this study is to determine the screening prevalence and risk factors of postpartum depression, among women who deliver in fourth hospital in the North of France in the context of the COVID epidemy.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
248
The mothers were administrated three questionnaires, (i) the Edinburgh Postnatal Depression Scale (EPDS), (ii) the State-Trait Anxiety Inventory (STAI-YA), and (iii) the Mother-to-Infant Bonding Scale (MIBS) in two stages, on days 2-3 after delivery and during a phone call between days 25-35.
CHU Amiens
Amiens, France
RECRUITINGVariation of prevalence of clinically-significant post-partum depressive symptoms
Variation of prevalence of clinically-significant post-partum depressive symptoms
Time frame: up to 35 days after delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.